腹腔镜胃癌根治术治疗进展期胃癌的临床效果分析

Clinical efficacy of laparoscopic radical gastrectomy in treatment of patients with advanced gastric cancer

  • 摘要: 目的 探讨腹腔镜胃癌根治术治疗进展期胃癌的临床疗效.方法 选取行腹腔镜胃癌根治术的进展期胃癌患者50例,分析其临床疗效.结果 50例患者均成功完成腹腔镜辅助胃癌根治术,全胃切除、近端胃切除、远端胃切除手术时间分别为(305 ±45)、(270 ±380)、(210±40) min,出血量分别为(260±40)、(230±30)、(110±40) mL,清扫淋巴结数目分别为(21.3±2.7)、(16.9±5.2)、(15.5±3.7)枚.手术后患者神经元特异性烯醇化酶(NSE)、癌胚抗原(CEA)、糖类抗原125(CA125)、糖类抗原19-9(CA19-9)、角蛋白21-1片段(CYFRA21-1)、高敏C反应蛋白(hs-CRP)水平与手术前相比均显著改善(P<0.05).结论 腹腔镜胃癌根治术能明显改善血清肿瘤标志物和hs-CRP水平.

     

    Abstract: Objective To explore the clinical efficacy of laparoscopic radical gastrectomy in treatment of patients with advanced gastric cancer.Methods A total of 50 patients with advanced gastric cancer were selected and treated with laparoscopic radical gastrectomy,and efficacy was analyzed.Results All the patients completed surgery successfully,the average operation time was (305 ± 45),(270 ± 380),(210 ± 40) min in patients with total gastrectomy,proximal gastrectomy,distal gastrectomy,the average blood loss volume was (305 ±45),(270 ±380),(210 ±40) min,and the average number of lymph nodes dissected was (21.3 ± 2.7),(16.9 ± 5.2),(15.5 ± 3.7) respectively.The levels of CEA,NSE,CAl25,CAl9-9,CYFRA21-1 and hs-CRP after operation were significantly lower that those before operation (P < 0.05).Conclusion Laparoscopic radical gastrectomy can significantly improve the levels of hs-CRP and serum tumor markers in the patients with advanced gastric cancer.

     

/

返回文章
返回